EXPRESS: Examining Pagoclone for Persistent Developmental Stuttering Study
Public ClinicalTrials.gov record NCT00216255. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An 8-week, Double-blind, Randomized, Multicenter, Flexible-dose, Placebo Controlled Pilot Study of Pagoclone in Patients With PDS Followed by a 52-week Open-label Extension
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of the study is to determine the effects of pagoclone on the symptoms of Persistent Developmental Stuttering, using a flexible dosing titration regimen on persistent developmental stuttering in patients 18 to 65 years of age.
Study identification
- NCT ID
- NCT00216255
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2005 (Type not available)
- Primary completion
- Jul 2011 (Actual)
- Completion
- Jul 2011 (Actual)
- Last update posted
- Sep 3, 2012
2005 – 2011
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pivotal Research Centers | Peoria | Arizona | 85381 | — |
| University of California, Irvine Medical School | Orange | California | 92868 | — |
| Pharmacology Research Institute | Riverside | California | 92506 | — |
| Pacific Clinical Research Medical Group | Upland | California | 91786 | — |
| University of South Florida College of Medicine | Tampa | Florida | 33613-4788 | — |
| Atlanta Institute of Medicine & Research-Atlanta Clinic | Atlanta | Georgia | 30328 | — |
| Davis Clinic PC | Indianapolis | Indiana | 46202 | — |
| Vince and Associates Clinical Research | Overland Park | Kansas | 66211 | — |
| Pivotal Research Centers | Royal Oak | Michigan | 48073 | — |
| Social Psychiatry Research Institute | Brooklyn | New York | 11235 | — |
| Social Psychiatry Research Institute | New York | New York | 10021 | — |
| Midwest Clinical Research Center | Dayton | Ohio | 45408 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| FutureSearch Trials | Austin | Texas | 78756 | — |
| University of Texas, Health Science Center | San Antonio | Texas | 78229 | — |
| University of Utah | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00216255, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 3, 2012 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00216255 live on ClinicalTrials.gov.